Cav3.2 expression was also assessed in clinical breast cancer samples stratified into the intrinsic molecular subtypes using the cancer genome atlas expression data (TCGA) [35] (Fig. 8a). The gene discussed is CACNA1H; the disease is breast carcinoma.